March 15, 2017
Japanese dermatology powerhouse Maruho has obtained exclusive worldwide rights to develop, manufacture, and commercialize a RORγt inhibitor originated by Toray, the two companies said on March 14. Under their deal, Maruho will be responsible for the agent’s global development from...read more